ArticleAmerican journal of translational research2019

Epigenetic silencing of miR-137 induces resistance to bicalutamide by targeting TRIM24 in prostate cancer cells.

Yonghui Guan et al.PubMed ↗Full text ↗

No numbers read from the abstract.